Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine.
ACS Medicinal Chemistry Letters April 10, 2025 DOI: 10.1021/acsmedchemlett.5c00112 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Neuroplasticity |
| Key findings | Innovations in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI platforms address challenges in neurological and psychiatric disorders, chronic pain, and computational accessibility. |
Abstract
Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a new frontier in precision medicine. These innovations address critical challenges in neurological and psychiatric disorders, chronic pain management, and computational accessibility. By harnessing the principles of receptor modulation, targeted delivery systems, and simplified AI integration, these breakthroughs promise transformative solutions for patient care and technological development.